Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Total Non-Current Liabilities (2016 - 2017)

Cytosorbents filings provide 6 years of Total Non-Current Liabilities readings, the most recent being $13.1 million for Q2 2017.

  • On a quarterly basis, Total Non-Current Liabilities rose 87.33% to $13.1 million in Q2 2017 year-over-year; TTM through Jun 2017 was $13.1 million, a 87.33% increase, with the full-year FY2016 number at $6.5 million, up 364.95% from a year prior.
  • Total Non-Current Liabilities hit $13.1 million in Q2 2017 for Cytosorbents, up from $8.2 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $13.1 million in Q2 2017 to a low of -$1.5 million in Q4 2014.
  • Median Total Non-Current Liabilities over the past 4 years was $6.8 million (2016), compared with a mean of $5.5 million.
  • The widest YoY moves for Total Non-Current Liabilities: up 402.59% in 2017, down 87.33% in 2017.
  • Cytosorbents' Total Non-Current Liabilities stood at -$1.5 million in 2014, then soared by 196.59% to $1.4 million in 2015, then skyrocketed by 364.95% to $6.5 million in 2016, then surged by 100.53% to $13.1 million in 2017.
  • The last three reported values for Total Non-Current Liabilities were $13.1 million (Q2 2017), $8.2 million (Q1 2017), and $6.5 million (Q4 2016) per Business Quant data.